CTKB

Cytek Biosciences, Inc.

• Benzinga·2h ago

  Cytek Biosciences Says Jury Finds In Cytek’s Favor On Three Of Four Asserted Patent Claims; To Challenge Remaining Finding; Jury Awarded Past Damages Consisting Of $20M In Lost Profits And $36M In Royalties

• TipRanks·3d ago

  Cytek Biosciences Balances Growth With Profit Pressures

• TipRanks·08/06 10:07

  Cytek: Solid Q2 Beat and Modest Outlook Raise, But Regional and Profitability Risks Justify Hold Rating

• Seeking Alpha·08/05 21:31

  Cytek Biosciences GAAP EPS of -$0.09 in-line, revenue of $48.1M misses by $0.51M

• TipRanks·08/05 21:21

  Cytek Biosciences reports Q2 EPS (9c), consensus (2c)

• TipRanks·08/05 21:21

  Cytek Biosciences sees FY26 revenue $207M-$212M, consensus $208.83M

• Benzinga·08/05 20:13

  Cytek Biosciences Q2 EPS $(0.09), Inline, Sales $48.140M Miss $48.610M Estimate

• Benzinga·08/05 20:06

  Cytek Biosciences Raises FY2026 Sales Guidance from $205.000M-$212.000M to $207.000M-$212.000M vs $208.767M Est

• Dow Jones·08/05 20:05

  Press Release: Cytek Biosciences Reports Second -2-

• Dow Jones·08/05 20:05

  Press Release: Cytek Biosciences Reports Second -3-

• NASDAQ·08/03 14:00

  Kyntra Bio (KYNB) Expected to Beat Earnings Estimates: Should You Buy?

• NASDAQ·07/23 17:19

  CSBR vs. CTKB: Which Life Sciences Stock Has Better Long-Term Upside?

• Benzinga·07/20 12:02

  Ryanair Posts Weak Q1 Results, Joins HDFC Bank And Other Big Stocks Moving Lower In Monday’s Pre-Market Session

• NASDAQ·07/16 08:03

  Cytek Biosciences Opens New Innovation Centre In Bellevue To Advance R&D; Stock Up

• Simply Wall St·06/30 11:05

  June 2026 Penny Stocks With Promising Potential